Come on Wilbur, you're smarter than this.
The shorts are upside down on this. There is only one other drug with a survival rate greater than 4.1 months, and that is 4.7.
I know a guy at big pharma who is in awe of these results. The Company handled themselves well. Somebody screwed the pooch with the trading, and I'm thrilled. I'll get more trades out of it, but better than that, this will leave a great trail for the new, improved SEC.
Yes, Shapiro is getting rave reviews from the inside. Couldn't believe it myself.